Hunter C Smith sold $6.6M of Rhythm Pharmaceuticals (RYTM)

Executed Aug 31, disclosed Sep 1, 1 day later.

Value, as filed

$6.6M

62,774 sh across 3 lots

Executed

Aug 31

the trade date, as filed

Disclosed

Sep 1

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

HS Hunter C Smith Chief Financial Officer profile →

Hunter C Smith (Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Rhythm Pharmaceuticals, Inc. (RYTM). The largest single filing was $6.6M of RYTM (62,774 sh across 3 lots, as filed), executed Aug 31.

The name

RYTM Rhythm Pharmaceuticals, Inc. RYTM · Healthcare · 47 filings in 24 months ticker →

Healthcare · Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United State…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Hunter C Smith in RYTM

RYTMSALE Rhythm Pharmaceuticals, Inc. $531K
5,269 sh across 4 lots
Exec Feb 17
Filed Feb 19 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $419K
4,179 sh across 2 lots
Exec Feb 10
Filed Feb 12 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $622K
5,881 sh across 3 lots
Exec Feb 4
Filed Feb 6 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $2.7M
28,088 sh across 2 lots
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $3.4M
42,120 sh across 3 lots
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $1.4M
23,400 sh across 2 lots
Exec May 30 2025
Filed Jun 3 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $127K
2,215 sh × $57.22
Exec Feb 19 2025
Filed Feb 19 2025 · 5:30 PM ET